Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia

NCT04445272 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

495

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Tocilizumab

Sponsor

Fundacion SEIMC-GESIDA

Collaborators

[object Object]
[object Object]